23andMe Holding Co.
General ticker "ME" information:
- Sector: Health Care
- Industry: Health Care Providers & Services
- Capitalization: $87.4M
23andMe Holding Co. does not follow the US Stock Market performance with the rate: -38.7%.
Estimated limits based on current volatility of 3.6%: low 3.03$, high 3.26$
Factors to consider:
- US accounted for 72.5% of revenue in the fiscal year ended 2023-03-31
- Current price 32.4% below estimated low
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-03-31 to 2026-03-31
- 2024-03-31 to 2025-03-31 estimated range: [4.75$, 15.31$]
- 2025-03-31 to 2026-03-31 estimated range: [5.22$, 15.39$]
Financial Metrics affecting the ME estimates:
- Negative: Non-GAAP EPS, $ of -0.67 <= 0.10
- Negative: Operating profit margin, % of -59.40 <= 1.03
- Negative: negative Net income
- Negative: Operating cash flow per share per price, % of -3.26 <= 2.35
- Positive: Inventory ratio change, % of -4.39 <= -1.03
- Positive: Interest expense per share, $ of 0 <= 0
- Positive: Investing cash flow per share, $ of -0.02 > -0.12
Short-term ME quotes
Long-term ME plot with estimates
Financial data
| YTD | 2022-03-31 | 2023-03-31 | 2024-03-31 |
|---|---|---|---|
| Operating Revenue | $271.89MM | $299.49MM | $219.64MM |
| Operating Expenses | $526.05MM | $623.50MM | $540.99MM |
| Operating Income | $-254.15MM | $-324.01MM | $-321.36MM |
| Non-Operating Income | $33.18MM | $9.58MM | $-345.27MM |
| Interest Expense | $0.28MM | $0.00MM | $0.00MM |
| R&D Expense | $189.38MM | $222.60MM | $205.36MM |
| Income(Loss) | $-220.97MM | $-314.43MM | $-666.63MM |
| Taxes | $-3.48MM | $-2.77MM | $0.07MM |
| Profit(Loss) | $-217.49MM | $-311.66MM | $-666.70MM |
| Stockholders Equity | $915.66MM | $713.94MM | $188.52MM |
| Inventory | $10.79MM | $10.25MM | $12.46MM |
| Assets | $1,152.07MM | $942.60MM | $395.17MM |
| Operating Cash Flow | $-166.83MM | $-165.39MM | $-164.32MM |
| Capital expenditure | $13.97MM | $11.30MM | $1.13MM |
| Investing Cash Flow | $-108.14MM | $-11.30MM | $-9.63MM |
| Financing Cash Flow | $546.00MM | $9.78MM | $3.58MM |
| Earnings Per Share* | $-9.96 | $-13.81 | $-1.40 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.